Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes products to women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
32
Frequently Asked Questions
What is Market Cap of Evofem Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Evofem Biosciences Inc market cap is $1.6M.
What is the 52-week high for Evofem Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Evofem Biosciences Inc 52 week high is $0.016 as of October 04, 2025.
What is the 52-week low for Evofem Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Evofem Biosciences Inc 52 week low is $0.0061 as of October 04, 2025.
What is Evofem Biosciences Inc stock price today?
Evofem Biosciences Inc stock price today is $0.013.
What was Evofem Biosciences Inc stock price yesterday?
Evofem Biosciences Inc stock price yesterday was $0.0135.
What is the PE ratio of Evofem Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Evofem Biosciences Inc’s P/E ratio is -0.20.
What is the Price-to-Book ratio of Evofem Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Evofem Biosciences Inc P/B ratio is -0.0230.
What is the 50-day moving average of Evofem Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Evofem Biosciences Inc 50-day moving average is $0.0109.
How many employess does Evofem Biosciences Inc has?